Study identification

PURI

https://redirect.ema.europa.eu/resource/34181

EU PAS number

EUPAS25338

Study ID

34181

Official title and acronym

Non-interventional cohort registry study to assess characteristics and management of patients with Merkel Cell Carcinoma in Germany (MCC-TRIM)

DARWIN EU® study

No

Study countries

Germany

Study description

This is a 5-year non-interventional (observational), longitudinal, multi-site cohort registry study focusing on various epidemiological and clinical aspects to be assessed in patients diagnosed with MCC in Germany. The design is an open cohort study design, with dynamic, renewed sampling, allowing for each eligible patient to have the same probability to be included throughout the inclusion period.

Study status

Finalised
Research institutions and networks

Institutions

Contact details

Communication Center Merck KGaA

Primary lead investigator
Study timelines

Date when funding contract was signed

Actual:

Study start date

Planned:
Actual:

Date of final study report

Planned:
Actual:
Sources of funding
Pharmaceutical company and other private sector 

More details on funding

Merck KGaA
Regulatory

Was the study required by a regulatory body?

Yes

Is the study required by a Risk Management Plan (RMP)?

EU RMP category 3 (required)